Combination of Kinetically Selected Inhibitors in Trans Leads to Highly Effective Inhibition of Amyloid Formation
- 28 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 132 (41), 14340-14342
- https://doi.org/10.1021/ja1046186
Abstract
Amyloid formation plays a role in over 25 human disorders. A range of strategies have been applied to the problem of developing inhibitors of amyloid formation, but unfortunately, many inhibitors are effective only in molar excess and typically either lengthen the time to the onset of amyloid formation, (the lag time), while having modest effects on the total amount of amyloid fibrils produced, or decrease the amount of amyloid without significantly reducing the lag time. We demonstrate a general strategy whereby two moderate inhibitors of amyloid formation can be rationally selected via kinetic assays and combined in trans to yield a highly effective inhibitor which dramatically delays the time to the appearance of amyloid and drastically reduces the total amount of amyloid formed. A key feature is that the selection of the components of the mixture is based on their effect on the time course of amyloid formation rather than on just the amount of amyloid produced. The approach is validated using inhibitors of amyloid formation by islet amyloid polypeptide, the causative agent of amyloid formation in type 2 diabetes and the Alzheimer’s disease Aβ peptide.Keywords
This publication has 28 references indexed in Scilit:
- The Ability of Rodent Islet Amyloid Polypeptide To Inhibit Amyloid Formation by Human Islet Amyloid Polypeptide Has Important Implications for the Mechanism of Amyloid Formation and the Design of InhibitorsBiochemistry, 2009
- Helix Stabilization Precedes Aqueous and Bilayer-Catalyzed Fiber Formation in Islet Amyloid PolypeptideJournal of Molecular Biology, 2009
- A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptidesProtein Engineering, Design and Selection, 2009
- Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the processProtein Science, 2009
- A role for helical intermediates in amyloid formation by natively unfolded polypeptides?Physical Biology, 2009
- Peptide and Protein Mimetics Inhibiting Amyloid β-Peptide AggregationAccounts of Chemical Research, 2008
- Small Molecule Protein–Protein Interaction Inhibitors as CNS Therapeutic Agents: Current Progress and Future HurdlesNeuropsychopharmacology, 2008
- Small-molecule aggregates inhibit amyloid polymerizationNature Chemical Biology, 2008
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature, 2004
- Therapeutic approaches to protein-misfolding diseasesNature, 2003